Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
2
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
celgene
2
×
clinical trials
2
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
johnson & johnson
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sarepta therapeutics
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
10x genomics
abbvie
aducanumab
affordable care act
aldeyra therapeutics
alex azar
allergan
What
bio
news
2
×
roundup
aducanumab
alzheimer’s
amyloid
angst
august
bagged
billions
biogen
biogen’s
biotech
brammer
busy
days
decisions
devices
drug
drugs
effects
failure
fda
felt
legacy
lost
nash
nods
opioid
past
regulatory
ripple
sarepta’s
seven
shkreli’s
slow
stumble
suits
tends
week
Language
unset
Current search:
celgene
×
news
×
" clinical trials "
×
biogen
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More